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The cannabinoid receptor-2 (CB2R) was initially thought to be the “peripheral canna-
binoid receptor.” Recent studies, however, have documented CB2R expression in the 
brain in both glial and neuronal cells, and increasing evidence suggests an important 
role for CB2R in the central nervous system inflammatory response. Intracerebral 
hemorrhage (ICH), which occurs when a diseased cerebral vessel ruptures, accounts 
for 10–15% of all strokes. Although surgical techniques have significantly advanced in 
the past two decades, ICH continues to have a high mortality rate. The aim of this 
study was to investigate the therapeutic effects of CB2R stimulation in acute phase 
after experimental ICH in rats and its related mechanisms. Data showed that stimulation 
of CB2R using a selective agonist, JWH133, ameliorated brain edema, brain damage, 
and neuron death and improved neurobehavioral outcomes in acute phase after ICH. 
The neuroprotective effects were prevented by SR144528, a selective CB2R inhibitor. 
Additionally, JWH133 suppressed neuroinflammation and upregulated the expression 
of microglial M2-associated marker in both gene and protein level. Furthermore, the 
expression of phosphorylated cAMP-dependent protein kinase (pPKA) and its down-
stream effector, cAMP-response element binding protein (CREB), were facilitated. 
Knockdown of CREB significantly inversed the increase of M2 polarization in microglia, 
indicating that the JWH133-mediated anti-inflammatory effects are closely associated 
with PKA/CREB signaling pathway. These findings demonstrated that CB2R stimulation 
significantly protected the brain damage and suppressed neuroinflammation by promot-
ing the acquisition of microglial M2 phenotype in acute stage after ICH. Taken together, 
this study provided mechanism insight into neuroprotective effects by CB2R stimulation 
after ICH.
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Figure 1 | The expression of cannabinoid receptor-2 (cB2r) after intracerebral hemorrhage (ich). The coronal section of specimen (a). Western blot test 
(B) of CB2R expression in total tissue around the hematoma (shown as the white quadrangles) at 0, 24, and 72 h after ICH, and the relative densitometric values 
analysis (c). Values were expressed as the mean ± SD, n = 6 in per group. *P < 0.05 vs. 0 h group; #P > 0.05 vs. 24 h group.
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inTrODucTiOn
Intracerebral hemorrhage (ICH) is a subtype of stroke with high 
morbidity and mortality, accounting for about 15% of all deaths 
from strokes (1). Pronounced inflammatory reactions play an 
important role in secondary brain injury following ICH (2, 3); 
various stimuli, including thrombin or glutamate, activate micro-
glia and initiate an inflammatory response, and subsequently 
release pro-inflammatory cytokines or chemokines to enhance 
neuroinflammation (3, 4).
Microglia are the resident macrophages of the brain and 
the first responders of the immune system (5). They are highly 
plastic cells that can assume diverse phenotypes and engage dif-
ferent functional programs in response to specific microenvi-
ronmental signals. In particular, stimulation with interferon-γ 
promotes classically activated microglia/macrophage (M1 
phenotype) that release destructive pro-inflammatory media-
tors, such as tumor necrosis factor-α (TNF-α) and interleukin-
1β (IL-1β), causing damage to healthy cells and tissues (6). In 
contrast, cytokines such as interleukin-4 and interleukin-10 
(IL-10) induce an alternative activated microglia (M2 pheno-
type) that generates anti-inflammatory cytokines, such as trans-
forming growth factor beta (TGF-β) and IL-10, which possess 
neuroprotective properties (7, 8). Microglia activation and M1/
M2 polarization have been reported in several types of acute 
central nervous system (CNS) injury, such as traumatic brain 
injury, spinal cord injury, and ischemic stroke (9, 10). Microglia 
activation and polarization also occur in hemorrhagic stroke 
(11,  12); however, their underlying mechanisms after ICH 
remain unclear.
The cannabinoid receptor-2 (CB2R) signaling pathway plays 
an important role in CNS injury via regulation of microglial 
activities (13, 14). In addition, the expression of CB2R on 
microglia mainly depends on the activation state of microglia 
(15). CB2R on activated microglia have been shown to modu-
late properties of microglial migration and infiltration into 
the CNS during active neuroinflammation and degeneration 
(16). In our previous study, we showed that CB2R stimulation 
attenuated microglial accumulation after germinal matrix hem-
orrhage (GMH) in neonatal rats (17). However, whether CB2R 
has effects on microglia polarization following ICH remains 
unknown.
In this study, we investigated the therapeutic effects of CB2R 
stimulation in acute phase following experimental ICH and its 
related mechanisms. We found that selective stimulation of CB2R 
significantly protected brain injury and suppressed neuroinflam-
mation by promoting M2 polarization of microglia. In addition, 
we also demonstrated that PKA/CREB signaling pathway was 
involved in, at least partially, the suppression of neuroinflam-
mation. These results indicated that CB2R may be a potential 
therapeutic target for ICH.
aniMals anD MeThODs
animals
Excluding 6 rats that died of an overdose of anesthetic before 
modeling, total 213 adult male Sprague-Dawley rats (250–300 g) 
were used for this study. Rats were housed under specific 
pathogen-free conditions and had free access to food and water. 
Animals were sacrificed at the endpoint under deep anesthesia 
using an overdose of intraperitoneal pentobarbital. All efforts 
were made to minimize suffering and animal numbers accord-
ing to the Guide for the Care and Use of Laboratory Animals; the 
study was approved by the Animal Care and Use Committee at 
the Third Military Medical University.
experimental Design
Experiment I
To determine the expression time course of CB2R after ICH, 18 
rats were randomly assigned into three groups: ICH 0 h (n = 6), 
ICH 24 h (n = 6), and ICH 72 h (n = 6). Perihematomal tissue 
(shown as the white quadrangle in Figure 1A) was collected to 
detect the protein expression of CB2R.
Experiment II
A total of 168 rats were randomly divided into four groups for 
the mechanism study: sham-operated (Sham group, n =  42), 
ICH +  Vehicle (ICH +  Vehi group, n =  42), ICH +  JWH133 
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(ICH + JWH group, n = 42), and ICH + JWH133 + SR144528 
(ICH +  JWH + SR group, n = 42). Sham group received only 
a needle insertion. The ICH +  Vehi group received an equal 
volume of vehicle, and the ICH  +  JWH group received an 
intraperitoneal injection of a selective CB2R agonist, JWH133 
(1.5 mg/kg, Tocris Bioscience, Minneapolis, MN, USA) at 1 h 
after surgery. The ICH +  JWH + SR group was treated with a 
selective CB2R antagonist, SR144528 (3  mg/kg, Santa Cruz 
Biotechnologies, Dallas, TX, USA) 3  min before JWH133 
(1.5 mg/kg) intraperitoneally. Brain water content (n = 6 in each 
group) and neurological scores (n = 6 in each group), including 
the modified Neurological Severity Score (mNSS) and forelimb 
placing test, were tested at 24 and 72 h after ICH. Gene levels 
of microglial M1/M2 markers and inflammatory cytokines in 
perihematomal tissue were evaluated at 6, 12, 24, and 72 h after 
ICH (n =  3 in each group). Western blots (n =  6 per group) 
and immunofluorescence staining (n = 6 per group) for protein 
expression of the tissues around the hematoma were conducted 
at 24 h post-ictus. The use of JWH133 and SR144528 was accord-
ing to the publication (18).
Experiment III
For further study of the mechanism, 27 rats were randomly 
assigned into three groups: ICH +  JWH133 +  Vehicle group 
(JWH + Vehi, n = 9), ICH + JWH133 + CREB-1 siRNA group 
(JWH +  si-CREB, n =  9), and ICH +  JWH133 +  scrambled 
siRNA group (JWH + scr-siRNA, n = 9). siRNA dilution buffer 
(Santa Cruz Biotechnologies, Dallas, TX, USA), CREB-1 siRNA 
(Santa Cruz Biotechnologies, Dallas, TX, USA), or scrambled 
siRNA (Santa Cruz Biotechnologies, Dallas, TX, USA) was 
intracerebroventricularly injected at 24 h before ICH modeling, 
and JWH133 was injected 1 h after surgery. PCR for gene levels 
(n = 3 in each group) and western blots for protein levels (n = 6 
in each group) were performed at 24 h after ICH in each group.
ich Model
To induce ICH, rats were anesthetized with an intraperitoneal 
injection of 5% chloral hydrate (350 mg/kg). A feedback-controlled 
heating pad was used to maintain body temperature at 37.0°C. 
A cranial burr hole (about 1  mm) was drilled, and a 29-gauge 
needle was inserted stereotaxically into the right basal ganglia 
(coordinates: 0.2 mm anterior, 5.5 mm ventral, and 4.0 mm lateral 
to the bregma) (19, 20). A total of 100 µl autologous arterial blood 
was infused at a rate of 10 µl/min using a microinfusion pump in 
each rat. The sham groups received only a needle injection into 
the right basal ganglia.
Brain Water content Measurement
Brain water content was examined 24 and 72  h after surgery. 
As previously described (21), animals were anesthetized with 
an intraperitoneal injection of 5% chloral hydrate (350 mg/kg). 
Brains were removed, and the tissue was sliced coronally (4 mm 
thickness) around the hematoma. Samples were divided into four 
parts: ipsilateral basal ganglia, ipsilateral cortex, contralateral basal 
ganglia, and contralateral cortex. Cerebellum was regarded as the 
internal control. Sample weights were determined immediately 
after removal and after drying for 24 h in a 100°C oven using an 
electric analytical balance. Brain water content (%) was calculated 
as (wet weight − dry weight)/wet weight × 100%.
assessment of Behavioral Outcome
Behavioral outcomes were assessed in a blinded fashion at 24 
and 72  h after surgery. The neurological abnormalities were 
assessed by the mNSS method. The evaluation was performed by 
an investigator blinded to the experimental scheme. The mNSS 
is a composite test of motor, sensory, and balance functions. 
Neurological function was graded on a scale of 0–18 (normal 
score, 0; maximal deficit score, 18) (22). For the forelimb placing 
test, each rat was tested 10 times for each forelimb; the percentage 
of trials that the rat placed the appropriate forelimb at the edge 
of the countertop in response to the vibrissae stimulation was 
determined. Testers were experienced and blind to the condition 
of the animal. The mean neurological score was evaluated by two 
blinded observers (23).
Fluoro-Jade c and Terminal duDP nick 
end labeling (Tunel) staining and cell 
counting
Fluoro-Jade C staining was used to assess neuronal degeneration. 
Briefly, sections were rinsed for 5 min in basic alcohol, followed 
by a 2-min rinse in 70% alcohol. Then, the sections were rinsed 
in distilled water and incubated in 0.06% KMnO4 for 10  min. 
They were rinsed in distilled water to remove excess KMnO4 and 
incubated in 0.0001% Fluoro-Jade C stain (Millipore, Boston, 
MA, USA) stain in 0.1% acetic acid for 10 min. Following Fluoro-
Jade C labeling, the sections were rinsed three times in distilled 
water, air dried for 10 min, cleared in xylene, and covered with 
DPX. TUNEL staining was performed using an in situ cell death 
detection kit-POD (Roche, Switzerland) to reveal DNA damage 
according to the manufacturer’s instruction (24). High-power 
images (×40 magnification) were taken around the hematoma 
using a digital camera. Fluoro-Jade C and TUNEL-positive cells 
were counted. Counts were performed on four areas in each brain 
section.
real-Time Pcr
PCR was performed and analyzed as previously described 
(25). Total RNA from brain tissue around the hematoma was 
extracted using Qiagen RNeasy mini kits. One microgram of 
RNA was reverse-transcripted and cDNA was synthesized using 
the PrimescriptTM RT kit (Takara, Dalian, China), substituting 
DNase and RNase-free water for no-RT controls. qPCR reactions 
were set up in 25  µl using SYBR Premix Ex TaqII kit (Takara, 
Dalian, China) and conducted on a CFX-96 Real-Time PCR 
Detection System (Bio-Rad, Hercules, CA, USA). The running 
procedure was 30  s at 95°C, 40 cycles of 5  s at 95°C, and 30  s 
at 60°C, following a melt curve. The qPCR primers were listed 
in Table S1 in Supplementary Material. Gene expression was 
quantified with standard samples and normalized with GAPDH. 
The data are expressed as normalized messenger RNA (mRNA) 
expression (fold mRNA increase).
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immunofluorescence staining
Immunofluorescence staining was performed as previously 
described (21). Briefly, free-floating slices were incubated with 
primary goat anti-Iba1 (1:200, Abcam, Cambridge, United 
Kingdom) at 4°C overnight, followed by Alexa 555-labeled rab-
bit anti-goat IgG (H + L) (1:500; Beyotime, Wuhan, China) sec-
ondary antibody (1 h, 37°C). Sections were washed and blocked 
with 10% normal goat serum for 1 h, then incubated overnight 
with mouse anti-CD68 (1:200, 1:500, AbD Serotec, Oxford, 
UK) or rabbit anti-CD206 (1:400, Santa Cruz Biotechnologies, 
Dallas, TX, USA). Finally, sections were incubated with the 
appropriate secondary antibodies for 1 h at 37°C. Colocalization 
was examined using a fluorescent microscope (Zeiss, LSM780).
Western Blot analysis
Western blot assays were performed as described previously (26). 
A total of 50 µg of prepared protein was loaded into each lane of 
SDS-PAGE gels. Gel electrophoresis was performed, and protein 
was transferred to a nitrocellulose membrane. The membrane 
was blocked in Carnation® non-fat milk and probed with primary 
and secondary antibodies. The following primary antibodies 
were used: rabbit anti-CB2R (1:500, Abcam, Cambridge, UK), 
mouse anti-CD68 (1:500, AbD Serotec, Oxford, UK), rabbit anti-
CD206 (1:500, Santa Cruz Biotechnologies, Dallas, TX, USA), 
rabbit anti-phospho-CREB (Ser133; 1:1,000, Cell Signaling 
Technology, Boston, MA, USA), rabbit anti-phospho-PKAC 
(Thr197; 1:1,000, Cell Signaling Technology, Boston, MA, USA), 
rabbit anti-β-tubulin (1:1,000, Abcam, Cambridge, UK), and 
mouse anti-β-actin (1:1,000, Santa Cruz Biotechnologies, Dallas, 
TX, USA). Then, membranes were incubated in the appropriate 
HRP-conjugated secondary antibody (diluted 1:1,000 in second-
ary antibody dilution buffer) for 1  h at 37°C. Protein bands 
were visualized using a nickel-intensified DAB solution, and 
the densitometric values were analyzed using Image J software. 
The housekeeping proteins β-tubulin and β-actin were used as 
internal controls.
intracerebroventricular infusion
Intracerebroventricular infusion was performed as described 
previously (27). Rats were anesthetized with an intraperitoneal 
injection of 5% chloral hydrate (350 mg/kg). The needle of a 10-µl 
Hamilton syringe (Microliter No. 701; Hamilton Company) was 
inserted through a burr hole in the skull into the left lateral ven-
tricle, according to the following coordinates: 1.5 mm posterior, 
4.2 mm ventral, and 0.8 mm lateral to the bregma. CREB-1 siRNA 
or an irrelevant scrambled siRNA [500 pmol each in 1 µl siRNA 
dilution buffer (Santa Cruz Biotechnology)] was injected (0.5 µl/
min) using a microinfusion pump at 24 h before ICH induction. 
The needle was removed 10 min later to prevent backflow. The 
burr hole was sealed with bone wax, and skin incisions were 
closed with sutures after the needle was removed. All rats received 
JWH133 (1.5  mg/kg) intraperitoneally 1  h after ICH. CREB-1 
siRNA consists of three different siRNA duplexes to improve the 
knockdown efficiency. All CREB-1 siRNA sequences were pro-
vided in 5′–3′ orientation as shown in Table S2 in Supplementary 
Material.
statistical analysis
Data are reported as the mean ± SD. Data were analyzed using 
one-way analysis of variance tests followed by Student–Newman–
Keuls tests. A non-parametric test (Kruskal–Wallis H) was used 
if the data were not normally distributed, followed by a Nemenyi 
test when a two-group comparison was necessary. Differences 
were considered statistically significant at P < 0.05.
resulTs
cB2r Was upregulated after ich injury
We first investigated whether CB2R alterations would respond 
to brain injury after ICH. Data showed that CB2R levels around 
hematoma (Figure 1A) were significantly increased at 24 h after 
ICH when compared with the ICH 0  h group (P <  0.05) and 
remained at a high level until 72 h (Figures 1B,C).
JWh133 reduced Brain Water content 
and improved neurobehavioral Outcomes 
both at 24 and 72 h after ich
To assess brain edema and neurobehavioral outcomes after 
ICH, brain water content and behavioral testings, including 
mNSS test and forelimb placing test, were used. Data showed 
that both at 24 and 72  h after surgery, rats subjected to ICH 
had increased perihematomal edema in the ipsilateral basal 
ganglia (P <  0.01 vs. Sham; Figures 2A,B). The animals also 
had significantly worse mNSS test performance (P < 0.01 vs. 
Sham; Figures  3A,B) and forelimb placing scores (P <  0.01 
vs. Sham; Figures 3C,D). In ICH + JWH groups, the perihe-
matomal brain edemas were significantly reduced (P <  0.05 
vs. ICH + Vehi; Figures 2A,B), and the neurobehavioral out-
comes were significantly improved (P < 0.05 vs. ICH + vehi; 
Figures 3A–D). All of these JWH133 effects were reversed by 
SR144528.
JWh133 attenuated neuronal Death  
and Dna Damage after ich
To investigate the neuronal degeneration after ICH, Fluoro-Jade C 
and TUNEL staining were used. At 24 h after ICH, the treatment 
of JWH133 significantly decreased the number of Fluoro-Jade 
C-positive cells (497 vs. 720/mm2 in ICH + Vehi group, P < 0.01) 
(Figures 4A,B). Similarly, the number of TUNEL-positive cells 
were significantly decreased in the ICH +  JWH group (524 vs. 
325/mm2 in ICH + Vehi group, P < 0.01) (Figures 4A,C). The 
result indicated that JWH133 could significantly attenuate neu-
ronal death and DNA damage after ICH.
Microglia Primarily Polarized to classic 
M1 Phenotype during the ich acute 
Phase, and JWh133 Promoted M2 
Polarization
To investigate the characteristics of microglial activation during 
the acute phase following ICH induction, gene levels of M1/M2 
Figure 3 | neurological deficit scores. Results of modified Neurological Severity Score test at 24 h (a) and 72 h (B), and forelimb placing test at 24 h (c) and 
72 h (D). Each experiment was repeated three times and the average value was taken for statistics. Vehi, Vehicle; JWH, JWH133; SR, SR144528. Values were 
expressed as the mean ± SD, n = 6 per group. **P < 0.01 compared with sham group; #P < 0.05 compared with ICH + Vehi group; &P < 0.05 compared with 
ICH + JWH group.
Figure 2 | Brain water content after intracerebral hemorrhage (ich). Brain water content in ipsilateral basal ganglia at 24 h (a) and 72 h (B) after ICH. 
Ipsi-BG, ipsilateral basal ganglia; Ipsi-CX, ipsilateral cortex; Cont-BG, contralateral basal ganglia; and Cont-CX, contralateral cortex; Cerebel, Cerebellum; Vehi, 
Vehicle; JWH, JWH133; SR, SR144528. Values were expressed as the mean ± SD, n = 6 in each group. **P < 0.01 compared with sham group; #P < 0.05 
compared with ICH + Vehi group; &P < 0.05 compared with ICH + JWH group.
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markers were investigated time dependently. After ICH, 
M1-associated markers CD32, CD68, and CD86 increased 
immediately and peaked at 6  h, and remained a high level to 
72 h (Figures 5A,C,E). M2-associated markers Arg-1, Ym-1, and 
CCL-22 increased slowly and peaked at 24 h, and kept a low level 
from 6 to 72 h (Figures 5B,D,F). However, the use of JWH133 
significantly inhibited the increase of M1-associated mRNA lev-
els (Figures 5A,C,E) and promoted M2-associated mRNA levels 
(Figures  5B,D,F), with the most obvious differences at 24  h, 
and all the effects could be significantly reversed by SR144528 
(Figures 5A–E). Consistent with the qPCR results, immunofluo-
rescent double-labeled staining and western blot results showed 
that the M1-associated marker CD68 was also more significantly 
upregulated than M2-associated marker CD206 at 24  h after 
ICH (Figures  6A,B). Treatment with JWH133 promoted the 
protein expression of CD206 and inhibited CD68 expression 
Figure 4 | cell death detection following intracerebral hemorrhage (ich). Fluoro-Jade C and terminal dUDP nick end labeling (TUNEL) staining for tissue 
around the hematoma in the ipsilateral basal ganglia at 24 h after ICH (a), and analysis of positive cell counting of Fluoro-Jade C (green) (B) and TUNEL (brown) 
(c) Green represents for FJC-positive cells and brown represents for TUNEL-positive cells. FJC, Fluoro-Jade C; Vehi, Vehicle; JWH, JWH133; SR, SR144528. 
Values were expressed as mean ± SD, n = 6 in each group. **P < 0.01 compared with sham group; #P < 0.05 compared with ICH + Vehi group; &P < 0.05 
compared with ICH + JWH group.
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(Figures 6A–C). These results indicated that CB2R stimulation 
could drive the acquisition of M2 polarization in microglia and 
reduce M1 phenotype.
inflammatory responses during ich Were 
inhibited by JWh133 Treatment
Inflammatory cytokine secretion plays an important role in 
brain injury after ICH. In this study, the mRNA expression 
levels of both pro-inflammatory (IL-1β, TNF-α, and iNOS) and 
anti-inflammatory cytokines (IL-4, IL-10, and TGF-β) in peri-
hematomal brain tissue were detected at different time points 
after ICH. Expression levels of pro-inflammatory cytokines 
increased immediately and IL-1β peaked at 6  h (Figure  7A), 
while TNF-α and iNOS (Figures  7C,E) peaked at 24  h post-
ICH. The gene levels of IL-4, IL-10, and TGF-β were upregulated 
at 6 h after ICH and reached a peak at 24 h (Figures 7B,D,F). 
However, treatment with JWH133 prevented the increase of 
IL-1β, TNF-α, and iNOS at 6  h after ICH induction, and the 
effect persisted to 72 h, with the most significant changes occur-
ring at 24 and 72 h (Figures 7A,C,E). In contrast, IL-4, IL-10, 
and TGF-β were significantly increased at 6 h, with the most 
significant changes occurring at 24 h (Figures 7B,D,F). All of 
the JWH133-mediated effects were prevented by treatment with 
SR144528.
pPKa–creB signaling Pathway Was 
upregulated by JWh133 Treatment
To further explore the underlying mechanisms, we tested the 
expression of pPKA–CREB signaling pathway. Results of western 
blot showed that pPKA and pCREB expression was significantly 
lower in ICH + Vehi group when compared with Sham group 
(P < 0.01), and the ICH + JWH group had significantly higher 
expression of pPKA (P < 0.01) and pCREB (P < 0.05) when com-
pared with the ICH + Vehi group (Figures 8A,B), indicating that 
pPKA–CREB signaling pathway was significantly upregulated by 
JWH133 treatment. The pretreatment of SR144528 prevented the 
upregulation effects.
pPKa–creB signaling Pathway Was 
involved in the JWh133-induced increase 
of Microglial M2 Polarization
cAMP-response element binding protein (CREB) in vivo knock-
down was performed to investigate the potential role of CREB 
in the effects of JWH133 induced the increase of microglial M2 
polarization and the decrease of M1 phenotype. Pretreatment 
with CREB-1 siRNA sufficiently downregulated the expression 
of CREB both at gene and protein levels (Figures S1A,B in 
Supplementary Material). Data showed that CREB-1 siRNA abol-
ished the JWH133-induced increase of M2-associated markers 
Figure 5 | M1/M2-associated markers of microglia at messenger rna level. CD32 (a), CD68 (c), and CD86 (e) are M1-associated markers. Arg-1 (B), 
Ym-1 (D), and CCL-22 (F) are M2-associated markers. Values were expressed as mean ± SD, n = 6 in each group. *P < 0.05, **P < 0.01 compared with sham 
group; #P < 0.05, ##P < 0.01 vs. ICH + Vehi group; &P < 0.05, &&P < 0.01 vs. ICH + JWH group.
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CD206 and Ym-1 at protein or gene level (Figures  9B,D,F), 
as well as the decrease of M1-associated markers CD68 and 
CD32 in protein or gene levels (Figures 9A,C,E). These results 
demonstrated that PKA/CREB signaling pathway plays a crucial 
role in the JWH133-mediated acquisition of M2 phenotype of 
microglia.
DiscussiOn
To our knowledge, this is the first study to demonstrate that 
JWH133, a selective CB2R agonist, reduces brain water content, 
neurological deficits, DNA damage, and neuron death in an 
autologous blood infusion rat ICH model. We also demonstrated 
that JWH133 suppresses neuroinflammation by driving micro-
glial M2 polarization through PKA/CREB pathway.
Increasing evidence indicates that inflammatory mechanisms 
are involved in stroke-induced brain injury, and microglia/
macrophage activation is thought to play a pivotal pathophysi-
ological role (1, 4). Overactivation of microglia/macrophages can 
exacerbate the inflammatory response after a stroke, resulting in 
blood–brain barrier disruption and neuronal damage, but also 
represents a promising target for stroke treatment. However, 
Figure 6 | M1/M2-associated markers of microglia at protein level. Perihematomal tissue was costained for CD68 (M1 marker) (green) and Iba1  
(microglia marker) (red), or CD206 (M2 marker) (green) and Iba1 (red) at 24 h after intracerebral hemorrhage (ICH) (a). Cell nucleus was stained with DAPI (blue). 
White arrows pointed to typical cells. n = 6 in per group. CD68 (B) and CD206 (c) were also tested using western blots. Values of the relative densitometric analysis 
were expressed as mean ± SD, n = 6 in each group. **P < 0.01 compared with sham group; ##P < 0.01 compared with ICH + Vehi group; &P < 0.05 compared 
with ICH + JWH group.
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Figure 7 | inflammation cytokines at messenger rna level in acute phase after intracerebral hemorrhage (ich). Interleukin-1β (a), iNOS (c), and tumor 
necrosis factor-α (e) are pro-inflammatory cytokines, and the IL-4 (B), interleukin-10 (D), and transforming growth factor beta (F) are anti-inflammatory cytokines. 
The values were mean ± SD, n = 6 in each group. *P < 0.05, **P < 0.01 compared with sham group, #P < 0.05; ##P < 0.01 compared with ICH + Vehi group; 
&P < 0.05, &&P < 0.01 compared with ICH + JWH group.
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broad suppression of microglia/macrophages may deprive the 
normal physiological defense mechanism of the CNS and lead to 
unintended side effects. Therefore, an improved understanding 
of the dual beneficial and detrimental roles of microglia in CNS 
injury and recovery is critical for improving stroke treatment (11).
Once activated, microglia/macrophages serve as a double-
edged sword during the battle between neurological damage and 
protection. Microglia can be activated to two polarization states: 
the M1, classically activated phenotype, and the M2, alternatively 
activated phenotype (28). Upon stimulation with lipopolysac-
charide or interferon gamma, microglia can be activated to 
the M1 phenotype and produce pro-inflammatory mediators, 
chemokines, redox molecules, costimulatory proteins, and major 
histocompatibility complex II (29, 30), exacerbating inflamma-
tory damage. Alternatively, microglia can also be activated to 
the M2 polarization state, which produces anti-inflammatory 
mediators that promote brain recovery by scavenging cell 
debris, resolving local inflammation, and are involved in tissue 
remodeling (31, 32). There is no doubt that it is very important 
to understand the status and function of polarized microglia 
activation for assessing inflammation progression and optimiz-
ing treatment.
Figure 9 | The relationship between pPKa–creB signaling pathway and microglial polarization. Western blot test and relative densitometric analysis 
(n = 6 in each group) of CD68 (a) and CD206 (B). Relative messenger RNA level of M1-associated markers CD68 (c) and CD32 (e), and M2-associated markers 
CD206 (D) and Ym-1 (F) (n = 3 in each group). The values were mean ± SD. *P < 0.05, **P < 0.01 compared with JWH + Vehi group.
Figure 8 | The expression of pPKa–creB signaling pathway at 24 h after intracerebral hemorrhage (ich). Total protein around the hematoma was 
extracted for investigation. Western blot analysis was used to detect the protein expression of (a) pPKA and (B) pCREB. Values of the relative densitometric analysis 
were expressed as mean ± SD, n = 6. *P < 0.05, **P < 0.01 compared with sham group; #P < 0.05, ##P < 0.01 compared with ICH + Vehi group; &P < 0.05, 
&&P < 0.01 compared with ICH + JWH group.
10
Lin et al. Neuroprotective Effects of CB2R in ICH
Frontiers in Immunology | www.frontiersin.org February 2017 | Volume 8 | Article 112
11
Lin et al. Neuroprotective Effects of CB2R in ICH
Frontiers in Immunology | www.frontiersin.org February 2017 | Volume 8 | Article 112
TBI was reported to create a severe cortical lesion, which led 
to chronic and persistent M1-primed activation that lasted for 
months to years. On the other hand, ICH often occurs after TBI. 
However, characteristic of microglial polarization and inflamma-
tory response after ICH remains unclear (33, 34). Xi et al. (11) 
found that ICH induces microglia activation and polarization in 
mice. They reported that M1 phenotypic markers were increased 
and reached a peak as early as 4 h, remained high at 3 days, and 
decreased 7 days after ICH, whereas M2 phenotypic markers were 
upregulated later than M1 markers, reaching a peak at day 1 and 
declined on day 7 after ICH, which is largely consistent with the 
findings of this study. The results confirmed our hypothesis that 
in the ICH acute phase, microglia/macrophage were largely acti-
vated toward the classical M1 phenotype, and JWH133 influenced 
the polarization process by promoting the anti-inflammatory M2 
phenotype.
We further investigated the intracellular molecular switches 
that regulate microglia/macrophage polarization. A recent 
breakthrough in research on microglia/macrophages has 
revealed that several transcriptional regulators may serve crucial 
roles in M2-associated marker expression (5, 35). Interferon 
regulatory factor 4 serves as a key transcriptional factor modulat-
ing M2 polarization, whereas the interferon regulatory factor 5 
and interferon regulatory factor 8 control macrophages toward 
M1 polarization. The nuclear hormone receptor peroxisome 
proliferator-activated receptor γ is an important transcriptional 
factor that mediates macrophages primed toward M2 polariza-
tion (36, 37). CB2R can couple to Gi proteins, and CB2R activa-
tion has been shown to activate cAMP/PKA (38). Additionally, 
it has been demonstrated that CB2R stimulation enhances CREB 
activation after cerebral ischemia through phosphorylation of 
AMPK (39). JWH133 was also found to attenuate apoptosis by 
activation of phosphorylated CREB-Bcl-2 pathway after suba-
rachnoid hemorrhage in rats (27). cAMP signaling is spatially 
and temporally regulated, allowing for the selective activation 
of a subset of targets. A-kinase anchoring proteins provided 
the platform for the assembly of signalosomes, which consist 
of cAMP effectors and their substrates. Among them, the role 
that cAMP plays in maintaining both microglia and monocyte 
homeostasis to prevent M1 activation has been reported. PKA 
was considered to be the cAMP receptor and seem to be closely 
associated with inflammation (40). Although CREB could be 
activated by various signaling pathways, including cAMP/
PKA, ERK1/2, and PI3K/Akt (41), in this study, we selectively 
detected PKA/CREB signaling pathway. CB2R agonist JWH133 
significantly enhanced the phosphorylated expression of PKA 
and CREB and knockdown of CREB significantly inversed the 
JWH133-induced increase of M2 polarization in microglia, 
indicating that PKA/CREB pathway participates in the effects 
of CB2R stimulation on microglia polarization during ICH. The 
results are in agreement with our previous study that the pro-
motion of microglial M2 polarization through the cAMP/PKA 
pathway participates in the CB2R-mediated anti-inflammatory 
effects during GMH (26).
Until now, most studies on microglial polarization have 
focused on TBI and cerebral ischemia, but relatively little 
was known about the polarization of microglia/macrophages 
following ICH (31). In this study, we demonstrated the neuro-
protective effects of a CB2R agonist via microglial polarization 
and the underlying molecular mechanisms that involved in 
microglial polarization, which may represent a new target for 
ICH therapy.
In summary, our results reveal microglia/macrophage acti-
vation and polarization after ICH in rats. Our data showed that 
the CB2R agonist JWH133 lessened the brain water content, 
improved neurobehavioral outcomes, and ameliorated DNA 
damage and neuron death, which resulted in alleviating brain 
injury after ICH. We also found that JWH133 inhibited the 
pro-inflammatory cytokine release and promoted microglia 
M2 polarization, leading to a beneficial anti-inflammatory 
cytokine release. JWH133 also facilitated the phosphorylation 
of PKA and its downstream effector, CREB. Moreover, knock-
down of CREB in  vivo abolished the effects of JWH133 on 
microglial polarization, indicating that the PKA/CREB sign-
aling pathway plays a critical role in the JWH133-mediated 
effects. Therefore, CB2R may provide a new target to modulate 
microglia/macrophage-mediated inflammatory injury and 
recovery after ICH.
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